Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ACS

This article was originally published in The Gray Sheet

Executive Summary

Lilly subsidiary Advanced Cardiovascular Systems begins marketing its ACS Edge coronary dilatation catheter, the company announced Oct. 7. The over-the-wire catheter, which was approved via a PMA supplement on July 29, was launched in Japan in June and in the U.S. and Europe in September. The ACS Edge has a smooth inner lumen and small crossing profile that is "achieved through a new, proprietary balloon-tip forming process," the firm says. The catheter, which is priced at $695, is 20 mm long and is available in widths from 1.5-4.0 mm. The company says that it is awaiting approval of PMA supplements, submitted in August, for ACS Edge catheters in lengths of 30 and 40 mm.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT001278

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel